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Abstract: 
Palm oil obtained from E. guineensis Jacq. Tenera is known to have about 44% of palmitic acid (C16:0). Palmitoyl-Acyl Carrier Protein Thioesterase (PATE) is 
one of the key enzymes involved in plastidial fatty acid biosynthesis; and it determines the level of the C16:0 assimilation in oilseeds. This enzyme’s activity in oil 
palm is responsible for high (> 44 % in E. guineensis Jacq. Tenera and 25 % in E. oleifera) content of C16:0 in its oil. By post-transcriptional PATE gene 
silencing, C16:0 content can be minimized for nutritional value improvement of the palm oil. The objective of this study was the construction of novel 
transformation vectors for PATE gene silencing. Six different transformation vectors targeted against PATE gene were constructed using 619 bp long PATE gene 
(5’ region) fragment (from GenBank AF507115). In one set of three transformation vectors, PATE gene fragment was fused with CaMV 35S promoter in 
antisense, intron-spliced inverted repeat (ISIR), and inverted repeat (IR) orientations to generate antisense mRNA and hair-pin RNAs (hpRNA). In another set of 
three transformation vectors with same design, CaMV 35S was replaced with Oil palm mesocarp tissue-specific promoter (MSP). The expression cassette of 
antisense, ISIR, and IR of PATE gene fragments were constructed in primary cloning vector, pHANNIBAL or its derivative/s. Finally, all 6 expression cassettes 
were sub-cloned into pCAMBIA 1301 which contains the Hygromycin
r and the GUS reporter genes for transformant selection and transformation detection 
respectively. The results of the RE analyses of the constructs and sequence analyses of PATE and MSP shows and confirms the orientation, size and locations of 
all the components from constructs. We hypothesize that 4 (pISIRPATE-PC, pIRPATE-PC, pMISIRPATE-PC and pMIRPATE-PC) out of 6 transformation 
vectors constructed in this study will be efficient and effective in palmitoyl-ACP thioesterase gene silencing in oil palm. 
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Background: 
Vegetable oils and fats are integral part of human diet. The world population is 
growing with an alarming rate, and the demand for vegetable oils and fats is 
increasing steadily. Coconut, corn, cotton, oil palm, peanut, rapeseed, 
safflower, sesame, soybean, sunflower, and flax are the main vegetable oil 
producing crops [1-2]. The African oil palm (E. guineensis Jacq.), and the 
American oil palm (E. oleifera) are cultivated in the tropics for vegetable oil 
production. In the African oil palm there are three fruit forms namely, Dura, 
Tenera, and Pisifera. Elaeis guineensis Jacq. Tenera is a hybrid of Dura (♀) 
and Pisifera (♂), and is known for the high oil yield [3]. Hence, for the 
commercial cultivation farmers and plantation companies favor E. guineensis 
Jacq. Tenera. One hectare of oil palm in good growing conditions produces 
about 4.5 tonnes (t) oil per year, 0.50 t kernel oil and 0.45 t palm kernel cake 
[4]. This yield is almost three times the yield of coconut, and more than ten 
times that of soybean [5]. Elaeis oleifera a close relative of the E. guineensis is 
low oil yielding and not preferred for the commercial plantation, even though 
its oil contains more (69 %) oleic acid in comparison to commercially 
cultivated oil palm, E. guineensis Jacq. Tenera. In the world market of fats and 
oils, palm oil is considered as a market leader, constituting about 35 % of the 
world trade in fats and oils. Malaysia is the largest producer and exporter of the 
palm oil, and accounts for about 50 % of the world’s palm oil output and 62 % 
of the net export trade in palm oil [5-6]. Palm oil has a great potential to fulfill 
the increasing demand for vegetable oil from both food and non-food 
industries. However, like other vegetable oils such as soybean oil, to get a good 
price in the market it is important to develop different varieties with desired 
fatty acid composition. To achieve this goal, conventional crop improvement BIOINFORMATION  open access 
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methods are not only tedious but also time-consuming [5]. Oil palm genetic 
engineering may save 80-90% of the time required for insertion of gene/s for 
new trait/s in it through conventional crop breeding [7]. Therefore, out of all 
existing methods available for crop improvement, perhaps genetic engineering 
is the best method to manipulate fatty acid profile in oil palm in a short period. 
Palm oil and palm kernel oil are the main commercial products of the oil palm 
fruits. Palm kernel oil is the main source of lauric acid (C12:0), which is 
mainly used to fulfill the needs of soap, detergent, and cosmetic industries [8]. 
Oil obtained from mesocarp of commercially cultivated oil palm (E. guineensis 
Jacq. Tenera) fruits contains 53.3% saturated fatty acids, while commercially 
less important E. oleifera contains 28% saturated fatty acids [5]. Among the 
saturated fatty acids, palmitic acid (C16:0) is predominantly accumulated. 
Elaeis guineensis Jacq. Tenera oil typically contains 44.0% C16:0, while in E. 
oleifera oil, it is 25.0% [5]. Lowering down the saturated fatty acid content in 
palm oil is one of the ways for palm oil nutritional value improvement. 
 
The PATE enzyme is known to have C16:0-ACP substrate specificity [9-11]. 
Therefore, it is necessary to knockout the expression of PATE gene in order to 
minimize the percentage of C16:0 in palm oil. Palm oil will be healthier for the 
human consumption and will get more price in the market if the C16:0 
percentage in palm oil could be reduced to make it low palmitate [12-14]. The 
silencing of PATE gene can be accomplished through any one of the several 
different methods of gene silencing such as, transcriptional gene silencing 
(TGS), cosuppression, post-transcriptional gene silencing (PTGS) using 
antisense, direct inverted repeats (IR), intron-spliced inverted repeat (ISIR) 
mediated gene silencing, and site-directed mutagenesis (SDM) [15-19]. 
Cosuppression and PTGS with antisense, IR and/or ISIR trans-genes markedly 
reduces the steady state mRNA levels of endogenous genes similar in 
transcribed sequence. These methods are proved to be very effective for gene 
silencing in oil producing, and other model plants like Arabidopsis [18-24]. A 
generic primary cloning vector, pHANNIBAL developed by CSIRO is very 
useful for the construction of novel transformation vectors with antisense, 
inverted repeats, and intron-spliced inverted repeats of the gene of interest [18-
19, 24-25]. This paper reports the construction of novel transformation vectors 
with constitutive and oil palm fruit mesocarp-tissue-specific promoter for the 
oil palm PATE gene silencing using pHANNIBAL, pCAMBIA 1301 and 619 
bp long 5’ region of oil palm PATE gene fragments. 
 
Methodology: 
Plasmid vectors and bacterial strains: 
Two cloning plasmid vectors, pHANNIBAL and pCAMBIA 1301 were used in 
the construction of 6 different transformation vectors for oil palm PATE gene 
silencing. The PCV, pHANNIBAL, a derivative of cloning vector pART7 was 
kindly provided by CSIRO, Australia [25-26]. The BCV, pCAMBIA 1301 was 
available in our laboratory (UKM, Bangi, Malaysia) [27]. The restriction 
enzymes map of PCV and BCV is shown in Supplementary Figure 1. The 
PCR cloning vector, pGEM®-T Easy was used for the cloning of PCR 
amplified antisense and sense PATE gene fragments. Bacterium, E. coli strain 
DH5-α was used for preparation of the competent cells to harbor the plasmids. 
Prepared competent cells were stored at –70 °C until the use.  
 
Construction of transformation vectors for PATE gene silencing: 
Plasmid, pPATE-RT is a recombinant PCR cloning vector (pGEM®-T Easy), 
which carries a 629 bp long (GenBank AF507115) fragment of E. guineensis 
Jacq. Tenera PATE gene previously isolated in our laboratory. We used this 
PATE gene fragment as template to synthesize antisense and sense PATE 
fragments in the vector construction. For the construction of 6 different 
transformation vectors for PATE gene silencing, standard gene cloning 
methods were used [28]. Construction of expression cassettes with antisense, 
ISIR and IR of PATE gene fragment was completed using pHANNIBAL. The 
expression cassettes from PCVs were then sub-cloned as a SacI-PstI fragment 
into pCAMBIA 1301. 
 
Plasmid DNA extraction:  
During preparation of constructs in PCV, selected and well-isolated colonies 
from the LB agar plates were inoculated aseptically and separately in universal 
bottles containing 10 ml LB medium, supplemented with 50 μg/ml Ampicillin 
(Ampicillin Sodium Salt, MF = C16H18N3NaO4S; Amersham Life Science). 
But, the BCV carries a Kanamycin resistant gene, and hence cultures were 
supplemented with 50 μg/ml Kanamycin. Cultures were incubated at 37 °C, 
250 RPM for 16 hours. Alkaline lysis method was used for pDNA preparation. 
For confirmation of the intactness, and quality of the extracted pDNA, it was 
electrophoresed on 1% agarose gel. 
 
 
PCR for RE sites addition and PATE amplification: 
To incorporate PATE gene fragment in antisense orientation in pHANNIBAL, 
XbaI and BamHI restriction sites were used. The forward primer [F-XbaI (5’- 
AGCTCTAGAATCTTTGGTCTTTCATTCCC-3’)] and reverse primer [R-
BamHI (5’- ATTGGATCCTTCCAATCAAGAAGGGTCC-3’)] were designed 
with flanking sequence of the XbaI, and BamHI restriction site (underlined 
nucleotides) respectively and used in amplification of the antisense PATE gene 
fragments. For amplification of 619 bp long sense PATE gene fragment, 
forward primer [F-XhoI (5’-ATTCTCGAGATCTTTGGTCTTTCATTCCC-
3’)] and reverse primer [R-EcoRI (5’-AACGAATTCTTCCAA 
TCAAGAAGGGTCC-3’)] were designed with XhoI, and EcoRI restriction site 
(underlined) flanking sequence, respectively. The PCR for amplification of 
antisense and sense PATE gene fragments was completed under following 
conditions. Hot start 94 °C for 5 min, followed by 35 cycles of 33 sec at 94 °C, 
1 min at 62 °C, 1.30 min at 72 °C and a final extension at 72 °C for 5 minutes. 
For the synthesis and amplification of the MSP, forward primer [PF-SacI/NotI 
(5’-GAGCTCGCGGCCGCGAATTTATCTGACAAAGGTGC-3’)] with 
flanking nt sequence for SacI, and NotI restriction sites (underlined) and 
reverse primer [PR-EcoRI (5’-CACGAATTCGAACTAGTAAGTGAAGA 
TCTTGG-3’)] with flanking nt sequence for EcoRI RE were used. 
Amplification of MSP by PCR was carried out using the following conditions: 
40 cycles of 33 sec at 94 °C, 1 min at 63 °C, 1 min and 30 sec at 72 °C, and a 
final extension of 1 cycle of 5 min at 72 °C.  
 
PCR product purification: 
The PCR products were purified from the PCR reaction mixture using 
NucleoSpin
® Extraction Kit (Ready-to-use system for fast purification of 
nucleic acids), BD Biosciences Clontech, USA. The DNA bands of expression 
cassettes and plasmid DNA were excised from agarose gel with the help of 
surgical blade, and DNA was purified using NucleoSpin
® Extraction Kit. 
Quantitative estimation of purified DNA was calculated using UV-160 A, UV-
visible recording spectrophotometer (SHIMADZU). 
 
Ligation reaction: 
Ligation reactions for incorporation of 619 bp long antisense and sense PATE 
gene fragments and MSP into pHANNIBAL and ligation reactions to 
incorporate expression cassettes into pCAMBIA 1301 were assembled in 10.00 
μl volume by adding: ~ 200 ng vector, ~ 600 ng insert, 10X Ligase buffer, 3 
units of T-4 DNA Ligase; sterile distilled water was added finally to adjust the 
final volume of reaction to 10 μl. Recombination reactions for cohesive ends 
were incubated at 16 (+1)  °C, whereas blunt end ligation reactions were 
incubated at 8 (+1) °C for 18 h.   
 
Transformation of E. coli competent cells: 
The preparation of frozen stocks of competent cells (using the protocol-I) and 
transformation of E. coli strain DH5-α competent cells with ligated product by 
using heat shock method was performed [28]. 
 
Analysis of recombinant plasmids by restriction enzymes: 
To confirm integration of antisense and sense PATE gene fragments, extracted 
recombinant plasmid DNA (20 μg pDNA) samples were double-digested with 
respective REs. For instance, for the confirmation of the antisense PATE gene 
fragment insert in pAPATE-H, it was double digested with XbaI-BamHI by 
incubating digestion reactions at 37°C, for 4 h. For the characterization of the 
recombinant plasmids, pDNAs were double-digested with different 
combinations of RE to confirm the size, orientation and location of the inserts 
and the components of the cassettes. 
 
Nucleotide sequencing: 
To confirm the identity of the PATE gene fragment or MSP promoter in 
constructs, nucleotide sequencing of the inserts was carried out using 
automated DNA sequencer. The pair of primers used for synthesis of PATE 
(antisense or sense) and MSP by PCR technique was used in sequencing 
reactions for the sequencing of respective inserts. Nucleotide sequence was 
analyzed by using nucleotide-nucleotide blast (blastn) program [29].  
 
Construction of transformation vectors using MSP:  
The MSP was isolated previously in our laboratory from Elaeis oleifera [30]. 
Three transformation vectors (with antisense, ISIR and IR of PATE gene 
fragment) were constructed for PATE gene silencing using MSP. From the 
already prepared expression cassette, CaMV 35S promoter was replaced with 
MSP to control expression of the constructs designed against oil palm PATE 
gene. MSP was used in the constructs to express constructs in oil palm 
mesocarp tissue-specific manner. 
  BIOINFORMATION  open access 
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Transfer of expression cassettes from PCV into BCV: 
The SacI and PstI restriction sites were used to separate expression cassettes 
with antisense, ISIR and IR of PATE gene fragment from the respective PCV. 
The separated and purified expression cassettes were incorporated as SacI-PstI 
fragment into BCV (pCAMBIA 1301). The BCV carries a Kanamycin resistant 
gene, and hence transformed bacteria were selected on LB-agar plates 
supplemented with 50 μg/ml Kanamycin. 
 
 
Figure 1: The expression cassettes from six transformation vectors constructed 
for PATE gene silencing. aPATE, antisense Palmitoyl-ACP Thioesterase gene 
fragment (619 bp); CaMV 35S, Cauliflower mosaic virus 35S promoter; MSP, 
Oil palm mesocarp tissue-specific promoter; sPATE, sense Palmitoyl-ACP 
Thioesterase gene fragment (619 bp); OCS, Octopine synthase terminator. 
*Figure drawing is not to the scale. 
 
Results: 
Six different types of transformation vectors for PATE gene silencing were 
constructed. A set of three constructs (with antisense, ISIR and IR of PATE) 
was constructed using constitutive (CaMV 35S) promoter. Another set of three 
constructs was with the same design of expression cassettes except that the 
CaMV35S promoter was replaced with MSP. Figure 1 shows the six different 
constructed expression cassettes and their design for PATE gene silencing. The 
expression cassette with antisense PATE gene fragment was prepared using 
619 bp long PATE gene fragment from plasmid, pPATE-RT and 
pHANNIBAL. Based on the restriction enzymes map of PCV and PATE gene 
fragment, antisense PATE gene fragment was incorporated in pHANNIBAL 
using XbaI and BamHI REs without discarding intron sequence. The intron 
sequence was kept as it is because it will be spliced out during the mRNA 
maturation; and hence its removal was not necessary. The strategy used for the 
construction of transformation vector (pAPATE-PC) with CaMV 35S promoter 
driven antisense PATE gene fragment is shown in Supplementary Figure 2. 
Double-digestion of pAPATE-H with SacI-ClaI released ~ 2173 bp long DNA 
fragment (lane 5, Figure 2A). This fragment contains CaMV 35S promoter and 
an intron. Double-digestion of pAPATE-H with XhoI-ClaI released DNA 
fragments of ~ 812 bp in length (lane 6, Figure 2A). This fragment is of intron. 
The DNA fragment of ~ 1447 bp in size was released from pAPATE-H as a 
result of its double-digestion with XhoI-XbaI (lane 7, Figure 2A). This 
fragment comprises an intron, and antisense PATE gene fragment. The double-
digestion of pAPATE-H with SacI-PstI released 3531 bp long entire expression 
cassette with CaMV 35S driven antisense PATE gene fragment (lane 8, Figure 
2A). After completion of the REs analysis of prepared antisense PATE gene 
fragments expression cassette, it was sub-cloned into pCAMBIA 1301 to have 
a selection marker, reporter gene, and other elements of the BCV. 
 
The REs analysis of the plasmid, pAPATE-PC was carried out to confirm the 
location, orientation, and length of the expression cassette and its elements. 
Digestion of plasmid, pAPATE-PC with EcoRI released 1373 bp long DNA 
fragment of CaMV 35S promoter (lane 3, Figure 2B). As expected double 
digestion of pAPATE-PC with EcoRI-PstI released two DNA fragments, 
smaller one was of 1373 bp long CaMV 35S promoter; and another bigger one 
was of 2164 bp in size (lane 4, Figure 2B). This fragment contains intron, 
antisense PATE gene fragment and OCS terminator of the expression cassette. 
The double-digestion of pAPATE-PC with SacI-KpnI released one DNA 
fragment of 1377 bp in size (lane 5, Figure 2B). This DNA fragment is of 
CaMV 35S promoter. Double-digestion of pAPATE-PC with SacI-PstI 
released the entire 3531 bp long ‘antisense PATE gene fragment expression 
cassette’ (lane 6, Figure 2B). Once the antisense PATE gene fragment is 
inserted in pHANNIBAL using XbaI and BamHI sites, the resulting plasmid 
can be used to make expression cassettes with ISIR and IR of PATE for the 
PATE gene silencing. For the construction of hpRNA generating 
transformation vector for PATE gene silencing, construct should have PATE 
gene fragments sequence either in ISIR or in an IR in its expression cassette. 
The strategy used for the construction of transformation vector (pISIRPATE-
PC) with CaMV 35S promoter driven ISIR of PATE gene fragment is shown in 
Supplementary Figure 3. The REs analysis of pISIRPATE-H and 
pISIRPATE-PC is depicted in Figure 2C & 2D, respectively. The 
pISIRPATE-H was used in construction of expression cassette with IR of 
PATE gene fragment. The intron fragment was taken out from pISIRPATE-H 
to make an expression cassette with direct IR of PATE gene fragments 
(Supplementary Figure 4). The REs analysis was carried out for both 
pIRPATE-H and pIRPATE-PC. The REs analysis results for pIRPATE-H and 
pIRPATE-PC are shown in Figure 2E & 2F, respectively. 
 
 
Figure 2: Agarose gel showing REs analysis of constructed plasmid vectors. 
(A) REs analysis of pAPATE-H. Lane 2, undigested pAPATE-H; lane 3, 
digested with SacI- XhoI; lane 4, digested with SacI-EcoRI; lane 5, digested 
with SacI-ClaI; lane 6, digested with XhoI-ClaI; lane 7, digested with XhoI-
XbaI; lane 8, digested with NotI; and lane 9, 100 bp DNA markers. (B) REs 
analysis of pAPATE-PC. Lane 2, undigested pAPATE-PC; lane 3, digested 
with EcoRI; lane 4, digested with EcoRI-PstI; lane 5, digested with SacI-KpnI; 
lane 6, digested with SacI-PstI; and lane 7, 100 bp DNA markers. (C) REs 
analysis of pISIRPATE-H. Lane 2, undigested pISIRPATE-H; lane 3, digested 
with SacI-XhoI; lane 4, digested with SacI-EcoRI; lane 5, digested with SacI-
ClaI; lane 6, digested with XhoI-ClaI; lane 7, digested with XhoI-XbaI; lane 8, 
digested with NotI; and lane 9, 100 bp DNA markers. (D) REs analysis of 
pISIRPATE-PC. Lane 2, undigested pISIRPATE-PC; lane 3, digested with 
EcoRI; lane 4, digested with EcoRI-PstI; lane 5, digested with SacI-KpnI; lane 
6, digested with SacI-PstI; and lane 7, 100bp DNA markers. (E) REs analysis 
of pIRPATE-H. Lane 2, undigested pIRPATE-H; lane 3, digested with SacI-
XhoI; lane 4, digested with SacI-BamHI; lane 5, digested with XhoI-XbaI; lane 
6, digested with NotI; and lane 7, shows the 100 bp DNA markers. (F) REs 
analysis of pIRPATE-PC. Lane 2, undigested pIRPATE-PC; lane 3, digested 
with SacI-XhoI; lane 4, digested with SacI-XbaI; lanes 5, digested with SacI-
PstI; and lane 7, 100 bp DNA markers; in A-F, Lane 1 shows λ DNA HindIII 
markers. 
 
The MSP was isolated previously in our laboratory and cloned in a PCR 
cloning vector, pGEM
®-T Easy [30]. This plasmid DNA was designated as 
pSESQ-PRO. Before PCR amplification of MSP its presence was confirmed in 
pSESQ-PRO by digesting it with EcoRI RE. Since EcoRI sites are located 
adjacent to the MSP DNA insert in pSESQ-PRO. The 1399 bp long MSP DNA 
fragment was released from the plasmid (pSESQ-PRO) as a result of its 
digestion with EcoRI (figure not shown). The released DNA fragment contains 
1293 bp of MSP, 96 bp of the gene, and 10 bp from the MCS of PCR cloning 
vector. In construction of the pMAPATE-PC, antisense expression cassette of 
PATE gene fragment from pAPATE-H was used by replacing CaMV 35S 
promoter with MSP. The strategy used in construction of pMAPATE-PC is 
shown in Supplementary  Figure 5. The REs analysis of plasmids, 
pMAPATE-H and pMAPATE-PC is shown in Figure 3A & 3B. The ISIR of BIOINFORMATION  open access 
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PATE gene fragment under MSP was constructed using pMAPATE-H and 
PCR amplified sense PATE fragment from pPATE-RT (Supplementary 
Figure 6). To confirm the presence of MSP and components of ISIR of PATE 
in expression cassette, REs analysis was carried out for pMISIRPATE-H and 
pMISIRPATE-PC. The results are shown in Figure 3C & 3D. The 
pMISIRPATE-H carries the ISIR of PATE gene fragments. Hence to make IR 
of PATE gene fragments in the expression cassette, intron was taken out by 
using KpnI and ClaI REs (Supplementary Figure 7). The sticky ends were 
made blunt by using T-4 DNA polymerase; and blunt ends were ligated to 
make IR of existing PATE gene fragments from the pMISIRPATE-H. The 
ligated plasmid was designated as pMIRPATE-H. The REs analysis of this 
plasmid and transformation vector (pMIRPATE-PC) was carried out; and the 
results are depicted in Figure 3E & 3F. 
 
 
Figure 3: Agarose gel pictures showing REs analysis of the constructed 
plasmid vectors in which PATE gene fragments were kept under the control of 
MSP.  (A) REs analysis of pMAPATE-H. Lane 2, the undigested DNA of 
pMAPATE-H; lane 3, digested with SacI-EcoRI; lane 4, digested with SacI-
KpnI; lane 5, digested with SacI-ClaI; lane 6, digested with EcoRI-ClaI; lane 7, 
digested with EcoRI-XbaI; lane 8, digested with SacI-PstI; and lane 9, 100 bp 
DNA markers. (B) REs analysis of pMAPATE-PC. Lane 2, undigested 
pMAPATE-PC; lane 3, digested with EcoRI; lane 4, digested with EcoRI-PstI; 
lane 5, digested with SacI-KpnI; lane 6, digested with SacI-PstI; and lane 7, 
100 bp DNA markers. (C) REs analysis of pMISIRPATE-H. Lane 2, 
undigested pMISIRPATE-H; lane 3, digested with SacI-EcoRI; lane 4, digested 
with SacI-KpnI; lane 5, digested with SacI-ClaI; lane 6, digested with EcoRI-
ClaI; lane 7, digested with EcoRI-XbaI; lane 8, digested with NotI; and lane 9, 
100 bp markers. (D) REs analysis of pMISIRPATE-PC. Lane 2, undigested 
plasmid DNA of pMISIRPATE-PC; lane 3, digested with EcoRI; lane 4, 
digested with EcoRI-PstI; lane 5, digested with SacI-KpnI; lane 6, digested 
with SacI-PstI, and lane 7, 100 bp markers. (E) REs analysis of pMIRPATE-H. 
Lane 2, Undigested plasmid DNA of pMIRPATE-H; lane 3, digested with 
SacI-EcoRI; lane 4, digested with SacI-PstI; lane 5, digested with EcoRI-XbaI; 
lane 6, digested with NotI; and lane 7, 100 bp markers. (F) REs analysis of 
pMIRPATE-PC. Lane 2, undigested pMIRPATE-PC; lane 3, digested with 
EcoRI; lane 4, digested with SacI-XbaI; lane 5, digested with SacI-PstI.; and 
lane 6, 1 kb DNA ladder. In A-F, Lane 1 shows λ DNA HindIII markers. 
 
Discussion: 
The presence of XhoI, EcoRI, KpnI, ClaI, HindIII, BamHI, XbaI, SacI, and PstI 
REs in pHANNIBAL DNA was confirmed prior to synthesis and insertion of 
antisense PATE into pHANNIBAL. It was necessary to confirm the identity of 
the plasmid, and to confirm uniqueness of REs so that the strategy can be 
implemented and the expected sizes of the fragments can be recognized. Our 
results confirmed the uniqueness of 9 REs sites (XhoI,  EcoRI,  KpnI,  ClaI, 
HindIII, BamHI, XbaI, SacI, and PstI) and the identity of the pHANNIBAL 
[25]. In construction of novel transformation vectors two (CaMV 35S and 
MSP) promoters were used. The use of the tissue-specific gene promoters 
enables tissue-specific expression of the gene/s. Therefore kernel and mesocarp 
tissue-specific gene promoters were isolated previously in our laboratory after 
isolation of tissue-specific genes by differential display method [30-32]. Fatty 
acid biosynthesis pathway in oil palms (E. guineensis Jacq. Tenera and E. 
oleifera) can be manipulated genetically at different levels using key genes and 
tissue-specific promoters. The reduction in level of the saturated fatty acid 
content in palm oil is one of the ways to improve nutritional value of palm oil. 
To achieve this goal, down-regulation of the PATE gene holds the key, since 
reducing palmitate content lowers down level of the saturated fatty acids 
significantly in palm oil.  
The research findings reported by Smith et al. (2000) showed that PTGS using 
antisense and/or cosuppression construct usually leads to modest proportion of 
silencing and silenced individuals in comparison to gene silencing induced by 
constructs with ISIR and IR [19, 25]. Therefore, a new generation of 
transformation vectors with ISIR, and IR of PATE gene fragments for PATE 
gene silencing was constructed. The construction of 2 transformation vectors 
with antisense construct (pAPATE-PC and pMAPATE-PC) was carried out 
along with the constructs with ISIR (pISIRPATE-PC and pMISIRPATE-PC) 
and IR (pIRPATE-PC and pMIRPATE-PC) of PATE for PATE gene silencing 
to compare the efficiency of the constructs in PATE gene silencing in oil palm. 
The CaMV 35S promoter was used for three reasons. Firstly, to determine 
whether there is an effect of PATE gene silencing on fatty acid profile in the 
leaves instead of waiting for flowering and fruiting of the transgenic oil palm to 
be obtained. Secondly, to determine the effect of PATE gene silencing on fatty 
acid profile of the palm oil obtained from mesocarp. And, the third reason was 
to compare the efficiency of CaMV 35S promoter with MSP [30].  
 
 
Figure 4: The predicted mRNA structure of the constructs encoding antisense 
PATE and self-complementary hpRNA (from ISIR and or IR of PATE gene 
fragments) to efficiently silence PATE gene (in oil palm). In the 6 constructs 
targeted against PATE gene, in 3 constructs expression of PATE is driven by 
CaMV 35S promoter; and in another 3 constructs expression is driven by MSP. 
Thick blue arrows indicates the 619 nt PATE sequence; long, black, thick lines 
in predicted RNA structure for antisense indicate endogenous PATE gene 
mRNA. Pink color loops indicate the loop formed by intron; pink dots indicate 
the nucleotides from intron junction sequences left after intron deletion; and 
short lines within the stem of hairpin structures indicates base pairing. *Note 
this figure is not drawn to the scale. 
 
The REs analysis of the PCVs and six (pAPATE-PC, pISIRPATE-PC, 
pIRPATE-PC, pMAPATE-PC, pMISIRPATE-PC, and pMIRPATE-PC) 
transformation vectors confirmed the length, orientation, presence and location 
of the MSP/CaMV 35S promoter and PATE gene fragment in the respective 
expression cassettes. The identity of the 619 bp long PATE gene fragments was 
confirmed by its sequencing from pAPATE-H and pAPATE-PC. Nucleotide 
sequence of antisense PATE gene fragment from pAPATE-PC showed 100 % 
homology with the template PATE sequence (Figure not shown). This result of 
sequence analysis confirmed the identity of the PATE gene fragments. All six 
transformation vectors targeted against PATE gene are ready for the oil palm 
genetic transformation experiments.  The genetic engineering of the oil palm to 
minimize C16:0 can be done using constructs constructed in this study. 
Immature zygotic embryos (IZEs), non-embryogenic and embryogenic-callus 
can be used as target tissues in the oil palm genetic transformation [33-34]. The 
pHANNIBAL is a derivative of pART7 [19, 25-26]. Both, the pART7 and 
pHANNIBAL are originally designed in such a way that the entire expression 
cassette cartridge can be removed from them as a NotI fragment to bring in 
directly into the specially designed BCV, pART27 [25-26]. However, the 
strategies used in this study highlights that various designs of expression 
cassettes constructed using pHANNIBAL (PCV) can be sub-cloned into 
pCAMBIA 1301. Hence, strategies used to construct transformation vectors in 
this study also highlight the compatibility of pHANNIBAL and pCAMBIA 
1301. 
 
The research findings of the Wesley et al., (2001) suggest that ihpRNA and 
hpRNA constructs containing sense and anti-sense arms ranging from 98 to 
853 nt leads to efficient silencing in a wide range of plant species [25]. In our 
all 6 constructs, the size of the PATE gene fragment used is 619 nt. Hence 
these constructs should be equally effective and efficient [19, 25]. Based on the BIOINFORMATION  open access 
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nt’s complementary nature, the predicted RNA structure of the constructs 
encoding antisense PATE and self-complementary hpRNA (from ISIR and or 
IR of PATE gene fragments) to efficiently silence PATE gene (in oil palm) is 
depicted in Figure 4. The PCV (pHANNIBAL) is a generic vector that allows 
simply, single PCR product from a gene of interest to be easily converted into a 
highly effective and efficient ihpRNA silencing construct [35]. Because of this 
PCV’s proven effectiveness and efficiency of resulting construct, this vector is 
a choice in constructing effective and efficient constructs for PTGS of targeted 
gene/s. This PCV is used in peanut to facilitate its genetic engineering for 
alleviating peanut allergy [36] and in other plants for PTGS of different genes 
[24, 35, 37]. By realizing the efficiency and effectiveness of the construct 
designs which pHANNIBAL enables, pHANNIBAL-like silencing vectors are 
also developed for gene silencing in fungi [38]. Therefore, we strongly believe 
that the integration of expression cassettes (containing ISIR and IR of PATE 
gene fragments) into oil palm genome will lead to the effective PATE gene 
silencing. As a result of it, C16:0 content will be minimized significantly in the 
palm oil.  It is reported that the silencing effect of such kind of constructs are 
stably inherited over many generations [35], and oil palm should not be 
exception for it. 
 
The optimized physical and biological parameters reported by Parveez et al. 
(2000) for the particle bombardment mediated genetic engineering of oil palm 
can be used to accelerate the genetic transformation of oil palm with constructs 
reported in this study to knockout the PATE gene expression [7]. Recently, 
constitutive and oil palm leaf-specific promoters (and their potential 
applications) has been reported by Masura et al. [39] and Masani et al. [40], 
respectively. These types of promoters can be used to drive expression 
cassettes of PATE gene for its silencing. However, we have used MSP which is 
known to regulate gene expression in oil palm fruit-tissue-specific manner [30]. 
Therefore, ISIR, IR and antisense construct of PATE gene fragments from 
pMISIRPATE-PC, pMIRPATE-PC, and pMAPATE-PC will express only in 
the fruit mesocarp tissues of the oil palm after its transformation. Whereas, 
ISIR, IR and antisense construct of PATE gene fragments from pISIRPATE-
PC, pIRPATE-PC, and pAPATE-PC will express constitutively. This will help 
to determine and compare the efficiency and effectiveness of the 2 promoter 
used. However, we strongly believe that genetic engineering of oil palm with 
pISIRPATE-PC, pIRPATE-PC, pMISIRPATE-PC and pMIRPATE-PC vectors 
will facilitate development of low saturated fatty acids producing oil palms [7]. 
Based on the literature and our understanding, we hypothesize that 4 
(pISIRPATE-PC, pIRPATE-PC, pMISIRPATE-PC and pMIRPATE-PC) out 
of 6 transformation vectors constructed in this study will be efficient and 
effective in PATE gene silencing in oil palm. Nevertheless, these constructs 
with efficient and effective construct design for PATE gene silencing are 
bound to facilitate the efforts of genetic engineering in oil palm to produce 
palm oil with low saturated fatty acids.   
 
Conclusion: 
Six different transformation vectors namely, pAPATE-PC, pISIRPATE-PC, 
pIRPATE-PC, pMAPATE-PC, pMISIRPATE-PC, and pMIRPATE-PC are 
constructed for the PTGS of the PATE gene. The results of the RE sites 
analyses and nucleotide sequence analyses of the PATE gene fragments and 
MSP confirms that 619 bp long PATE gene fragments insert are at the right 
locations and orientations in the constructs. The PATE gene fragment insert is 
in antisense orientation in pAPATE-PC and pMAPATE-PC, in ISIR orientation 
in pISIRPATE-PC and pMISIRPATE-PC, and in direct IR orientation in 
pIRPATE-PC and pMIRPATE-PC. In all six transformation vectors, all the 
elements of the respective expression cassettes targeted against PATE gene are 
at the right place and orientation. But, to take this research forward, 
transformation of E. guineensis Jacq. Tenera and E. oleifera with constructed 
constructs needs to be done in order to obtain transgenic oil palms for the low 
C16:0 palm oil in a reasonable time. 
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Supplementary material: 
 
 
Figure 1: Restriction maps of plasmid vectors used in construction of transformation vectors to silence the PATE gene expression; (A) Primary cloning vector 
(PCV), pHANNIBAL provided by CSIRO, Australia [19, 25]; (B) Binary cloning vector (BCV), pCAMBIA 1301 (Source: provided by UKM Laboratory) [27]. 
MCS stands for multiple cloning sites. 
 
 
Figure 2: Strategy used in construction of transformation vector with CaMV 35S driven antisense PATE gene fragment. Plasmid, pPATE-RT is a plasmid which 
carries 629 bp long 5’ region of the PATE gene. Plasmid, pHANNIBAL was used as PCV; and plasmid, pCAMBIA 1301 was used as BCV. Refer to 
Supplementary Figure 1A and B for restriction map of pHANNIBAL and pCAMBIA 1301. LB, left (T-DNA) border; RB, right (T-DNA) border; aPATE, 
antisense PATE; OCS, octopine synthase terminator;  and CaMV 35S, cauliflower mosaic virus 35S promoter. Figure is not drawn to the scale. BIOINFORMATION  open access 
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Figure 3: Illustration of the strategy used in construction of transformation vector with CaMV 35S driven ISIR of PATE gene fragments. Plasmids, pAPATE-H 
and pCAMBIA 1301 were used as PCV, and BCV, respectively. LB, left (T-DNA) border; RB, right (T-DNA) border; s/aPATE, sense/antisense PATE; OCS, 
octopine synthase terminator; and CaMV 35S, cauliflower mosaic virus 35S promoter. Note that this figure is not drawn to the scale. 
 
 
Figure 4: The diagrammatic sketch of the strategy used in construction of transformation vector with CaMV 35S driven IR of PATE gene fragments.  Plasmids, 
pISIRPATE-H and pCAMBIA 1301 were used as PCV and BCV, respectively. LB, left (T-DNA) border; RB, right (T-DNA) border; s/aPATE, sense/antisense 
PATE gene fragments; OCS, octopine synthase terminator; and CaMV 35S, cauliflower mosaic virus 35S promoter. Note this figure is not drawn to the scale. BIOINFORMATION  open access 
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Figure 5: Strategy used for the construction of transformation vector with MSP driven antisense PATE gene fragment. Plasmids, pAPATE-H and pCAMBIA 
1301 were used as PCV and BCV, respectively. LB, left (T-DNA) border; RB, right (T-DNA) border; MSP, mesocarp tissue-specific promoter; aPATE, antisense 
PATE gene fragment; OCS, octopine synthase terminator; and CaMV 35S, cauliflower mosaic virus 35S promoter. Note that this figure is not drawn to the scale. 
 
 
Figure 6: Strategy used in construction of transformation vector with MSP driven ISIR of PATE gene fragments. Plasmid, pMAPATE-H was used as a primary 
cloning vector, whereas plasmid, pPATE-RT was used as a template for the synthesis of 619 bp long sense PATE gene fragment. LB, left (T-DNA) border; RB, 
right (T-DNA) border; MSP, mesocarp tissue-specific promoter; s/aPATE, sense/antisense PATE; OCS, octopine synthase terminator; and CaMV 35S, cauliflower 
mosaic virus 35S promoter. Note that figure is not drawn to scale. 
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Figure 7: The diagrammatic sketch of the strategy used in construction of transformation vector with IR of PATE gene fragments under the control of MSP. 
Plasmid, pMISIRPATE-H was used as PCV. LB, left (T-DNA) border; RB, right (T-DNA) border; s/aPATE, sense/antisense PATE gene fragments; OCS, 
octopine synthase terminator; and CaMV 35S, cauliflower mosaic virus 35S promoter. Note that diagrammatic sketch is not drawn to the scale. 